270: Your guide to Wegovy’s blockbuster heart study
The Readout Loud
00:00
Wigovi: A Weight Loss Drug That Reduced the Risk of Major Cardiovascular Complications
The long awaited results of a landmark Wigovi study finally came through this week. The news is that Novo Nordics blockbuster weight loss drug significantly reduced the risk of major heart problems for patients diagnosed with obesity. But experts have far more questions than they do answers at this point.
Transcript
Play full episode
